1882:HKEXSANIGEN Analysis
Data as of 2026-06-13 - not real-time
¥1,512.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Toa Road Corp is trading at 1,512 JPY, just above its 20‑day SMA (1,511.2) but well below the 50‑day (1,590.9) and 200‑day (1,660.1) averages, indicating a short‑term bounce within a longer‑term bearish framework. The RSI sits at 43, suggesting neutral momentum, while the MACD histogram has turned positive, hinting at emerging bullish pressure. Valuation metrics are compelling: the stock’s P/E of 17.5 is less than half the industry average of 30.6, and the DCF‑derived fair value of ~2,777 JPY implies upside of over 80%. However, the dividend payout ratio of 156% raises concerns about dividend sustainability. Fundamentals show modest profitability (net margin 2.8%) and a slight revenue decline of 2.1%, but a strong cash position (13.9 B JPY) offsets a modest debt load (4.6 B JPY). Volatility is elevated at 20.7% over 30 days, yet beta is low (~0.13), indicating limited market‑wide risk.
Given the sizable valuation gap, low systematic risk, and improving technical signals, the stock presents a value‑oriented opportunity for investors with a longer horizon, while short‑term traders should monitor the 1,467 JPY support and 1,567 JPY resistance levels for entry cues.
Given the sizable valuation gap, low systematic risk, and improving technical signals, the stock presents a value‑oriented opportunity for investors with a longer horizon, while short‑term traders should monitor the 1,467 JPY support and 1,567 JPY resistance levels for entry cues.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering near support at 1,468 JPY
- Positive MACD histogram indicating early bullish momentum
- High dividend yield but unsustainable payout ratio
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Valuation upside of >80% versus DCF fair value
- Low beta and strong cash position reducing downside risk
- Technical momentum building toward 1,567 JPY resistance
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation gap relative to industry peers
- Stable earnings base with solid free cash flow generation
- Low systematic risk and favorable dividend yield if payout improves
Key Metrics & Analysis
Financial Health
Revenue Growth-2.10%
Profit Margin2.82%
P/E Ratio17.5
ROE6.31%
ROA4.04%
Debt/Equity8.41
P/B Ratio1.3
Op. Cash Flow¥12.2B
Free Cash Flow¥9.0B
Industry P/E30.6
Technical Analysis
TrendBearish
RSI43.3
Support¥1,468.00
Resistance¥1,567.00
MA 20¥1,511.20
MA 50¥1,590.90
MA 200¥1,660.06
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86
Valuation
Fair Value¥2,776.89
GradeUndervalued
TypeValue
Dividend Yield5.95%
Risk Assessment
Beta0.13
Volatility20.67%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.